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Abstract 
Novel, simple, rapid and reliable High-Performance Thin-Layer Chromatographic (HPTLC) methods were 
developed and validated for the analysis of Formoterol Fumarate Dihydrate (FFD) in bulk and in in-house capsules 
formulation.  HPTLC quantitation of FFD was done at UV detection of 281 nm and analysis was performed on (10 cm × 10 
cm) aluminium sheets precoated with silica gel 60-F254 (E. Merck) as stationary phase and ethyl acetate: methanol: 
triethylamine (3.2:1.5:0.3 v/v) as mobile phase. Quantitation by HPTLC method was performed over the concentration 
range of 400 - 900 ng/band. The HPTLC method resulted into compact and well resolved band for FFD at retention factor 
(Rf) of 0.51 ± 0.3. Linear regression analysis data for calibration of HPTLC method represented good linear relationship 
with regression coefficient; r
2
 = 0.999. The developed methods were validated for precision, robustness, ruggedness, 
accuracy, sensitivity as per guidelines laid by International Conference on Harmonisation (ICH). FFD was subjected to acid 
and alkali hydrolysis, oxidation, neutral, photo and thermal degradation. The drug undergoes degradation under acidic, 
basic, oxidation, and thermal conditions. This indicates that the drug is susceptible to acid, base, oxidation and thermal 
conditions. The degraded product was well resolved from the pure drug with significantly different Rf value. Statistical 
analysis proved that the developed methods were precise, robust, sensitive and accurate and can be used effectively for the 
analysis of FFD in bulk and pharmaceutical formulations. 
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1. Introduction 
Formoterol Fumarate Dihydrate (FFD), N-[2-
hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl) propan-2- 
yl] amino} ethyl) phenyl]formamide [1] [Figure 1], is a 
long-acting β2-selective adrenoceptor agonist, used as 
Bronchodilator and also used in Chronic Obstructive 
Pulmonary Disease (COPD). [2]. 
 
Figure 1: Chemical Structure of FFD 
 In literature survey few analytical methods 
includes LC-MS [3] method for quantitation of FFD 
inhuman urine, Assay of Formoterol by HPLC [4] and 
spectrophotomertic method by formation of colour 
chromogens of FFD has also studied for the estimation of 
FFD in pharmaceutical formulation. 
Many analytical methods such as RP-HPLC [5-7], 
UV- spectrophotometry [8,9] have been reported for 
simultaneous determination of FFD in combination with 
Budossunide and Memontasone Furoate in Pharmaceutical 
formulation. 
Analysis of pharmaceuticals is an imperative and 
chief aspect of the complete drug development process. 
Therefore, simple and rapid methods for quality control of 
commercial formulations are needed. High – Performance 
thin – layer chromatography (HPTLC) is an important 
separation technique since many samples can be 
chromatographed simultaneously with small amount of 
solvent [10]. 
Forced degradation experiments are used to 
relieve the development of analytical methodology, to 
achieve better insightful of the stability of the active 
pharmaceutical ingredient (API) and the drug product, and 
to provide information about degradation pathways and 
degradation products [11]. However, no literature is 
available for which deals with the stress degradation profile 
of   LTD in accordance with ICH guidelines using any of 
the above analytical techniques. 
The objective of this work was to develop a 
stability-indicating High-Performance Thin-Layer 
Chromatography (HPTLC) / Densitometry method for 
analysis FFD. Since there are no reports of analysis of FFD 
alone in formulations, the method has also been used for 
analysis of FFD in capsules. This paper describes an 
accurate, specific, repeatable, and stability-indicating 
method for analysis of FFD in the presence of its 
degradation products. The method was validated in 
accordance with the guidelines of the US Pharmacopoeia 
[12] and the International Conference on Harmonization 
(ICH) [13]. 
 
2. Materials and Methods  
Formoterol fumarate dihydrate standard was 
supplied as a gift sample from a well reputed 
pharmaceutical industry. Ethyl acetate and Methanol 
(HPLC Grade) and Triethylamine used during study were 
procured from (E.Merck, Mumbai, India). Capsules 
containing 12 mcg of  
2.1 Equipments and Experimental conditions 
A Camag TLC system (Muttenz, Switzerland) 
comprising of Camang Linomate 5 automatic sample 
applicator, Hamilton syringe (100 µL), Camang TLC 
scanner 3, Camang winCATS software (version 1.3.0), 
Camang twin trough chamber (10 cm x 10 cm) and 
ultrasonicator; ENERTECH Electronics Pvt. Ltd., India  
was used during the study.  
Chromatographic study was carried out on 
aluminium-backed precoated silica gel 60-F254 (10 cm × 10 
cm) HPTLC plates having thickness 200 μm (E.Merck, 
Mumbai, India). Prior to use; the  HPTLC plates were pre-
washed and dried in oven at 105 ᴼC. Densitometric 
detection was performed with a Camag TLC Scanner 3 
(Camag, Muttenz, Switzerland) installed with winCATS 
software (version 1.3.0). Drug standards and samples were 
applied on the HPTLC plates using Linomat 5 (Camag) 
applicator. Ten microliter samples were spotted 6 mm from 
the edge of the plates. The plates were developed in twin 
trough glass chamber (20 cm × 10 cm) (Camag, Muttenz, 
Switzerland). The volume of mobile phase was 10 ml. 
Mobile phase components were mixed prior to use and the 
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development chamber was left for saturation with mobile 
phase vapours for 20 min before each run at room 
temperature. Development of the plate was carried out by 
the ascending technique to a migration distance of 8 cm 
followed by drying with the help of an air drier. 
Densitometric scanning was done in absorbance-
reflectance mode at 281 nm using a deuterium lamp 
emitting a continuous UV-spectrum between 190 nm - 400 
nm. 
2.2 Preparation of Stock Standard Solution and Study 
of Calibration Curve  
A stock standard solution was prepared by 
dissolving 10 mg FFD in a 100 ml volumetric flask 
containing 25 ml of methanol and  sonicated for 10 min 
using ultrasonicator and volume was made up to the mark 
to get a stock standard solution of 0.1 mg/ml of FFD.  
From the standard solution, appropriate volumes of 4 - 9 ml 
were transferred with the help of previously calibrated 
pipette (10.0 ml) into series of 10 ml volumetric flasks. A 
fixed volume 10 µL was applied on the HPTLC plates to 
obtain concentration 400, 500, 600, 700, 800 and 900 
ng/band of FFD respectively. Each concentration was 
applied six times to the plates and plates were developed as 
described above. Peak areas were plotted against 
corresponding concentrations to obtain the calibration plot. 
2.3 Validation of Analytical Method 
2.3.1 Precision 
The repeatability of sample application and 
measurement of peak area were measured using six 
replicates of the same band (600 ng/band of FFD). Intra-
day and inter-day precision for analysis of FFD was 
measured at three different concentrations 600, 700, and 
800 ng/band. 
2.3.2 Accuracy 
The accuracy of the experiment was established 
by over spotting drug standard solution to the pre-analyzed 
sample solution. The recovery study was performed at 
three different levels i.e. 80, 100, and 120%. The 
experiment was demonstrated in triplicate. 
2.3.3 Ruggedness and Robustness  
The ruggedness of the method was performed by 
two different analysts using same operational and 
environmental conditions. 
For robustness study, few parameters like mobile 
phase composition (±0.5ml), mobile phase volume (±2ml) 
development distance (±0.5cm) and duration of saturation 
(±5min.), were changed deliberately and the effects on the 
results were examined. The robustness and ruggedness of 
the method was assessed at concentration (600 ng/band) for 
six times. 
2.3.4 Limits of Detection (LOD) and Quantification 
(LOQ) 
The LOQ and LOD were calculated by the use of 
the equations LOD = 3.3 × N/B and LOQ = 10 × N/B 
where ‘N’ is the standard deviation of the peak areas of the 
drug (n = 3), taken as a measure of the noise, and ‘B’ is the 
slope of the corresponding calibration plot. The signal to 
noise ratio was determined. The LOD was regarded as the 
amount for which the signal- to-noise ratio was 3:1 and 
LOQ as the amount for which the signal-to-noise ratio was 
10:1. The LOD and LOQ estimated at concentration range 
400 – 500 ng/band. 
2.3.5 Specificity 
The specificity of the method was ascertained by 
analyzing standard FFD and FFD extracted from capsule 
formulation. The band for FFD in sample was confirmed 
by comparing the Rf and spectra of the band with those 
obtained from standard. The peak purity of FFD was 
assessed by comparing spectra acquired at three different 
positions on the band, i.e. peak-start (S), peak-apex (M), 
and peak-end (E). 
2.4 Analysis of marketed formulation  
Twenty capsules were weighed and powdered. An 
amount of powder equivalent of 10 mg of FFD was 
weighed accurately and extracted with 100 ml methanol in 
100 ml flask using reciprocating shaker for 10 min (the 
optimal extraction time) and transferred to a 100 ml 
volumetric flask. After filtration through a Whatman filter 
paper, extract (6μl; 600 ng/band) was applied to a HPTLC 
plate followed by development and scanning as described 
above. The analysis was repeated in six times. 
2.5 Forced Degradation Studies 
Acid and base-induced degradation was attempted 
by separately adding 10 mg of FFD in 10 ml each of 0.1 N 
HCl and 0.1 N NaOH solutions separately. These solutions 
were kept for 8 h in the dark in order to exclude the 
possible degradative effect of light. The solutions (1 ml) 
were neutralized and diluted to 10 ml with methanol. The 8 
µL of the resulting solutions (800ng/band) were applied to 
HPTLC plate and chromatograms were obtained as 
described above.  
For oxidative degradation, 10 mg of FFD added in 
10 ml of 3% (v/v) hydrogen peroxide solution and kept in 
dark for 8 h. The solution (1 ml) was diluted to 10 ml with 
methanol and treated as described for acid and base-
induced degradation.  
For dry heat degradation, FFD powder was placed 
in an oven at 70°C for 8 h. A solution of 10 mg FFD in 10 
ml methanol was prepared from the dry heat treated 
sample. The solution (1 ml) was diluted to 10 ml with 
methanol and treated as described for acid and base-
induced degradation.  
To assess the neutral degradation, a 10 mg of FFD 
added in 10 ml water and photochemical degradation was 
studied by exposing 1 mg/ml solution in methanol to sun 
light for 72 h. The resulting solutions (1 ml) were diluted to 
10 ml with methanol and analyzed using process described 
above.   
 
3. Results and Discussion 
3.1 Selection of the Optimum Mobile Phase 
The HPTLC procedure was optimized to develop 
a stability-indicating assay method to quantify FFD in bulk 
and capsules formulation. The drug standard was applied 
on HPTLC plates and chromatographed with different 
composition of mobile phases. The high resolution and 
reproducible peak was achieved using ethyl acetate: 
methanol: triethylamine (3.2:1.5:0.3 v/v) as mobile phase 
and chamber saturation period was for 20 min. In this 
mobile phase FFD showed compact spot with Rf = 0.51 
when the scanning was performed at 281 nm [Figure 2]. 
 
Figure 2: Typical Chromatograph of FFD showing Rf 
0.51 
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3.2 Calibration Plots 
Calibration curves were constructed by plotting 
peak area against drug quantity per band.  A good linearity 
was obeyed in the concentration range of 400 – 900 
ng/band; calibration plot is y = 8.400x - 1.228 and 
correlation coefficient (r
2
 > 0.99) as shown in [Figure 3] 
All measurements were repeated six times. 
 
Figure 3: Calibration Curve of FFD 
 
3.3 Validation of developed stability indicating method 
3.3.1 Precision and % Recovery study  
The precision of the method was studied as 
repeatability, intra-day and inter-day variations. The results 
from study of precision are shown in Table 1. The 
developed method was found to be précised as the RSD 
values for repeatability and intra-day and inter-day 
precision studies were < 2%, respectively as recommended 
by ICH guideline. 
 
Table 1: Intra-day and inter-day precision [n = 6] 
Precision 
Amount 
[ng per 
band] 
% Amount 
found 
±SD 
RSD 
[%] 
Repeatability 
(n=6) 
600 600.04 5.89 0.98 
Intra-day 
(n=3) 
600 592.70 01.66 0.28 
700 693.22 04.27 0.62 
800 800.17 01.01 0.13 
Inter-day 
(n=3) 
600 589.77 06.33 1.07 
700 691.16 13.10 1.90 
800 796.93 08.32 1.04 
When the method was used for extraction and 
subsequent analysis of FFD in capsule dosage forms after 
spiking with 80, 100, or 120% excess drug the recovery 
was found 99.06 – 99.59 %, as listed in Table 2.  
 
Table 2: Results from recovery studies [n = 3] 
Amount of drug 
Added to capsule 
formulation [%] 
Theoretical 
content 
[ng per band ] 
Recovery 
[%] 
RSD 
[%] 
80 720 99.42 0.49 
100 800 99.06 0.65 
120 880 99.59 0.32 
 
3.3.2 Ruggedness and Robustness 
The standard deviation of peak areas was 
calculated for each condition and % RSD was less than 2 
%. The low values of % RSD are indicative of the 
robustness and ruggedness of the method. The results from 
study of robustness are shown in Table 3.  
 
Table 3: Results from robustness testing [n = 6] 
                          Conditions                                                                       RSD [%]
Mobile phase composition (± 0.5 ml)   1.42 
Mobile phase volume (± 2 ml)                                             1.59 
Development distance (± 0.5 cm)   1.58 
Plate saturation time (± 5 min) 1.60 
Time from application to chromatography (±10 min)                1.05 
Time from chromatography to scanning (±10 min)                    0.78 
 
2.3.3 Limits of Detection (LOD) and Quantification 
(LOQ) 
Detection limit and quantitation limit for signal-
to-noise ratios of 3:1 and 10:1 were 17.06 ng and 53.35 ng, 
respectively, which indicate adequate sensitivity of the 
method. 
3.3.4 Specificity 
Peak purity for FFD was assessed by comparing 
spectra acquired at the peak -start (S), peak -apex (A) and 
at the peak -end (E) positions of the band, r
2
(S,M) = 0.996 
and r
2
(M,E) = 0.998. Good correlation (r
2
 = 0.999) was also 
obtained between FFD standard and FFD extracted from 
capsules FFD [Figure 4].  
 
 
Figure 4: Overlain Peak - purity spectra of FFD standard and FFD extracted from capsules at peak start, peak apex and 
peak end position in HPTLC 
 
These correlation values indicate the ability of the method to separate and specifically detect FFD from sample 
solutions.  
The validation data are summarized in Table 4. 
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Table 4: Summary of validation data 
Parameter Results 
Linear range [ng per band] [n = 6]           400 – 900 
Correlation coefficient   0.999 
Limit of detection [ng]                                                         17.60
Limit of quantification [ng]                                                 53.35 
% Recovery [n = 9]   99.06 – 99.59 
Precision [%RSD]          
Repeatability [n = 6]   0.98 
         Intra-day [n = 3]      0.13 – 0.62 
         Inter-day [n = 3]                                                                          1.04 – 1.90 
Ruggedness [% RSD]  
        Analyst – I [n = 6] 1.07 
        Analyst – II [n = 6]                                                                        1.10 
Robustness    Robust 
Specificity      Specific 
 
3.4 Analysis of marketed formulation 
The results obtained for the amount of FFD in 
capsules as against the label claims were in good 
agreement. The amount of drug estimated using this 
method was found to be 98.72 ± 0.96, demonstrated that 
there was no interference from the excipients usually 
present in capsule formulation. It may therefore be inferred 
that degradation of FFD had not occurred in the 
formulations analyzed by the method described above. The 
good performance of the method indicated the suitability of 
this method for routine analysis of FFD in capsules dosage 
forms. 
3.5 Forced Degradation studies 
The chromatograms obtained from samples 
exposure to acidic, alkaline, oxidative and dry heat 
degradation depicted well separated bands of pure FFD and 
some additional peaks at different Rf values. No major 
degradation product was seen when sample were subjected 
to neutral and photochemical degradation. The % of 
degradation products with their Rf values is listed in Table 
5. Peak purity of these FFD peaks during stability studies 
was also examined by comparing the respective spectra 
obtained from RP-HPTLC/ densitometry at the peak start 
(S), peak apex (M), and peak end (E). The values of r (S, 
M) and r (M, E) were all > 0.99 with standard spectra FFD 
peak, indicating the purity of peaks of the remaining FFD. 
The result of forced degradation shown in [Figure 5]. 
 
 
Figure 5: Degradation Study of FFD 
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Table 5:  Results from degradation studies 
Condition Time (h) Rf of degradation product % of degradation product 
Acid, 0.1 N HCl, RT 8 0.32 and 0.63 12.75 and 16.71% 
Base, 0.1 N NaOH, RT                   8 0.23 and 0.77 9.22 and 49.97% 
H2O2, 3% (w/v), RT     8 0.61 6.25 % 
Dry heat (70 ± 2°C)                         8 0.84 and 0.97 35.24 and 17.53% 
Neutral degradation                         8 Not detected  
Photo degradation                           72 Not detected  
 
4. Conclusions 
This densitometric HPTLC method is quite 
simple, accurate, highly precise, reproducible, rapid, 
sensitive and specific. It was successfully used to study the 
stability of FFD under different stress degradation 
conditions. Statistical analysis proves that the method is 
repeatable and selective for the analysis of FFD as the bulk 
drug and in pharmaceutical formulations, without 
interference from excipients. It can also be utilized 
successfully for determination of the chemical stability and 
shelf life of FFD in capsules formulations, because it has 
stability-indicating properties. 
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